Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enact Holdings (ACT) Cash & Equivalents (2020 - 2025)

Enact Holdings has reported Cash & Equivalents over the past 6 years, most recently at $582.5 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $582.5 million for Q4 2025, down 2.83% from a year ago — trailing twelve months through Dec 2025 was $582.5 million (down 2.83% YoY), and the annual figure for FY2025 was $582.5 million, down 2.83%.
  • Cash & Equivalents for Q4 2025 was $582.5 million at Enact Holdings, up from $543.6 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for ACT hit a ceiling of $699.0 million in Q2 2024 and a floor of $425.8 million in Q4 2021.
  • Median Cash & Equivalents over the past 5 years was $606.2 million (2024), compared with a mean of $584.3 million.
  • Biggest five-year swings in Cash & Equivalents: soared 41.23% in 2023 and later decreased 19.27% in 2025.
  • Enact Holdings' Cash & Equivalents stood at $425.8 million in 2021, then rose by 20.65% to $513.8 million in 2022, then rose by 19.84% to $615.7 million in 2023, then fell by 2.64% to $599.4 million in 2024, then fell by 2.83% to $582.5 million in 2025.
  • The last three reported values for Cash & Equivalents were $582.5 million (Q4 2025), $543.6 million (Q3 2025), and $613.0 million (Q2 2025) per Business Quant data.